Affected products
A. NEURAY SURGICAL PATTIES
B. NEURAY SURGICAL STRIPS
C. MEROCEL SURGICAL PATTIES
As part of a notification to all manufacturers of neurosurgical patties, Medtronic Xomed was informed by the Food and Drug Administration's (FDA) Center for Devices and Radiological Health (CDRH) of a potential post-market safety concern associated with the use of neurosurgical patty devices.
The potential safety concern identified by the FDA “is related to clinical consequences when some patties, which are designed to be x-ray detectable or radiopaque to assist with post-procedural removal in the event of a missing device, are not visible during x-ray imaging."
To address this potential concern, Medtronic is including additional information in the instructions for use regarding these issues to further clarify the use of these devices to health care practitioners. The updated instructions for use includes the precautions that will help reduce the potential for clinical consequences when some neurosurgical patties, which are designed to be x-ray detectable or radiopaque to assist with post-procedural removal in the event of a missing device, are not visible during x-ray imaging.